Medtech start-up machineMD from the Sitem StartUp Club (SSC) convinced investors and secured CHF 3.2 million - oversubscribing its seed round by 50%. machineMD is developing a medical device for the early diagnosis of neurological disorders including brain tumours via neuro-ophthalmic examinations.
Dominic Senn, CEO of machineMD, said: "This seed round showed us the Sitem StartUp Club is not only a place where medtech start-ups get office space, find a lively community and coaching, but also gave us access to an exclusive and active investor club. For us, as well as for other medtech start-ups, such a comprehensive funding offer with a strong financing component is a key success factor that shows how well Bern is positioned in the field of translational medicine."
To read the full article, please visit: www.med-technews.com